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CORRELATION BETWEEN IMPAIRMENT AND MOTOR PERFORMANCE
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John-Henry Anderson, DPT1 and Scott A. Wilkins, DPT1
From the 1Motor Control Research Laboratory, School of Physical Therapy and Rehabilitation Science, The University of
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Objective: The main purposes of this study were to examine,
in subjects with chronic hemiparesis following a stroke: (i ) the
correlations between tests of muscle tone, stiffness, spasticity,
paresis and co-contraction, and (ii ) the correlations of these
tests and measurements of impairment to upper extremity
motor performance.
Design: Prospective, cross-sectional, correlation matrix using
sample of convenience.
Subjects: Thirteen subjects with chronic hemiparesis second-
ary to a cerebrovascular accident (stroke) were tested.
Methods: Subjects were assessed using the Fugl-Meyer Upper
Extremity Motor Assessment, modified Ashworth scale, deep
tendon reflexes, and muscle characteristics that included
quantification of muscle stiffness, paresis and co-contraction
during a voluntary reaching task and during passive move-
ments. Surface electromyographic and myotonometric muscle
stiffness data were obtained during movement trials.
Results: Biceps and triceps brachii muscle paresis and excess
biceps brachii co-contraction during voluntary reaching had
the highest correlations to decreased motor performance.
Muscle tone measurements did not have significant correla-
tions to upper extremity performance.
Conclusion: Paresis of elbow flexors and extensors and excess
co-contraction of the biceps brachii during voluntary reaching
appear to be most predictive of upper extremity motor
performance. Results are discussed in relation to the specific
challenges these findings pose for spastic paresis clinical
management.
Key words: stroke, myotonometer, paresis, co-contraction,
spasticity.
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INTRODUCTION
The development of upper extremity spastic paresis is common
following stroke and other neurological disorders. Spastic
paresis is comprised of positive and negative symptoms that
occur to varying degrees in each patient. Positive symptoms
include spasticity (velocity dependent resistance to passive
stretch), hypertonia (resistance to passive stretch), increased
muscle stiffness (tissue displacement per unit of applied force)
and excessive co-contraction between agonist (shortening) and
antagonist (lengthening) muscles. Negative symptoms include
muscle paresis (decreased muscle activation) and discoordina-
tion. It has long been of interest to discern the relationships of
these positive and negative symptoms and impairments to each
other and to motor performance.
Passive tests (i.e. tests performed on a non-voluntarily moving
arm), such as deep tendon reflexes (DTRs), and modified
Ashworth scores (MAS) are typically used to characterize
muscle tone changes. Newer methods, such as myotonometric
muscle stiffness measurements, are also typically done on a
resting or passively moved limb. It remains unclear whether or
not these passive tests are representative of tone changes that
occur during voluntary movements or have a relationship to
each other and to motor performance.
The few studies that have attempted to explore the relation-
ships among neurological tests, impairments and motor perfor-
mance have been equivocal. There are conflicting reports
regarding the degree to which altered stretch reflexes (1, 2),
resistance to passive stretch (3, 4), excessive antagonist muscle
co-contraction (57), and musculo-tendonous stiffness (2, 8)
affect motor performance. It is likely that, in part, equivocal
results can be attributed to study specifics. For instance, past
assessments of antagonist muscle co-contraction of subjects
post-stroke were typically measured during maximal voluntary
contractions of the agonist muscle (5, 7). Other studies assessed
voluntary submaximal efforts (6). It remains unknown whether
co-contractions observed during maximal efforts of subjects
relate to their muscle activation levels during submaximal
voluntary reaching tasks. This was one question addressed in
the present study.
The study had 3 specific aims. The first was to examine, in
subjects with chronic spastic hemiparesis following a stroke, the
relationships among impairments and upper extremity motor
performance. The second was to examine the relationships
between passive neurological tests (DTRs, MAS), muscle
characteristic data (stiffness, paresis, co-contraction) and motor
performance. The third aim was to determine the degree of
correlation between myotonometric biceps brachii muscle stiff-
ness measurements obtained from a passively moved arm to
measurements obtained during a voluntary reaching task.
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We hypothesized that triceps brachii muscle paresis, increased
biceps brachii stiffness, and MAS would have the highest
correlation to motor performance as measured by the Fugl-
Meyer Upper Extremity Motor Function test. Secondly, we
hypothesized that biceps brachii DTRs, muscle stiffness, and
MAS would correlate to each other. Thirdly, it was hypothe-
sized that passive and voluntary movement myotonometric
measurements of biceps brachii stiffness would be significantly
different but correlated.
MATERIAL AND METHODS
This study received approval from The University of Montana’s
Institutional Review Board and was conducted in accordance with the
Declaration of Helsinki. Testing of subjects took place, following
informed consent, in The Motor Control Research Laboratory at The
University of Montana.
Subjects
Thirteen subjects, with a history of stroke, with a mean age of 62.8 (SD
9.5) years, participated in this study. Table I summarizes subject
characteristics. Subjects were screened using the following inclusion/
exclusion criteria. To be included in the study, subjects had to have: (i ) a
diagnosis of spastic-type hemiparesis involving the upper extremity of at
least 10 months’ duration with accentuated upper extremity DTRs and a
modified Ashworth scale (MAS) score of/1, (ii ) an ability to follow
simple commands, and (iii ) an ability to initiate a reaching movement
involving shoulder horizontal abduction and elbow extension. Exclusion
criteria included: (i ) signs of extra-pyramidal involvement, such as
resting or active tremors or dystonic postures, (ii ) orthopedic involve-
ment of the upper extremity (e.g. acute sprains, history of surgeries, joint
replacements), (iii ) pain during active or passive upper extremity
movement and (iv ) current use of any tone-altering medications.
Study design
The study was a prospective, cross-sectional research design in which all
data were collected during a single, 90-minute experimental session.
Subject histories, DTRs (scale/05), MAS (9), and Fugl-Meyer Upper
Extremity Motor Function (10) data were obtained first. The DTRs,
MAS and Fugl-Meyer Upper Extremity Motor Function data were
acquired with the subject in a sitting position using standardized clinical
procedures. Subjects were then positioned in an upper extremity
armature for muscle stiffness, strength and co-contraction data collec-
tion during biceps and triceps brachii maximal voluntary contraction
(MVC) trials, voluntary reaching to a target and during passive
movements that mimicked the speed and trajectory of the subjects’
voluntary movements. Muscle stiffness data were collected with a
Myotonometer. All other muscle characteristic data were collected using
surface electromyography (sEMG).
Instrumentation
Upper extremity armature testing apparatus. An upper extremity
armature device was constructed and used for the study. The device
was used so that subjects did not have to support the arm against gravity,
to ensure identical planar movements among all trials, to isolate subject
movements solely to the elbow and shoulder joints, and to permit
measurements of accelerations and joint velocities during movements.
The armature supported the upper extremity and permitted only flexion
and extension movements of the elbow and shoulder horizontal
abduction and adduction. The armature was mounted to a table and
consisted of a proximal plexiglass support that suspended the arm from
the axilla to the elbow. The distal plexiglass cuff supported the forearm
from the elbow to the metacarpals. There was an articulation at the
elbow and the shoulder joints that used needle bearings and thrust plates
to approximate frictionless movement in the horizontal plane at the
shoulder and the elbow. The armature was equipped with an accel-
erometer (Biopac model TSD109) and 2 electrogoniometers (Biopac
model TSD130B). The accelerometer was secured at the distal end of the
forearm support and the electrogoniometers were secured at the
armature’s elbow and shoulder joints. The armature was also equipped
with a plastic dowel that extended from the wrist plate to slightly beyond
the subjects’ fingers. This dowel acted as the pointing device that
subjects used to point to the intended target. The target was a 14 cm
circle with concentrically smaller circles decreasing by 2 cm in diameter,
similar to a rifle target. The armature and target were mounted to a table
that represented the subject workspace.
Electromyography. sEMG data were acquired and analyzed using the
BIOPAC Systems MP150 and Acknowledge 3.7.3 software. Electrodes
(Ag-AgCl, 2 cm between active sites, onsite pre-amplification; Ther-
apeutics Unlimited) were placed over the muscle belly following
appropriate skin preparation. Signals were sampled at 2 kHz, high
pass filtered at 20 Hz and amplified 25 K as needed. A reference
electrode was placed on the opposite forearm just proximal to the volar
aspect of the wrist. sEMG data were used to measure biceps brachii,
triceps brachii and posterior deltoid muscle activity during MVCs, and
during voluntary and passive reaching tasks.
Myotonometer†. The Myotonometer (Neurogenic Technologies, Inc.)
was used to quantify biceps brachii muscle stiffness. The Myotonometer
is a patented, FDA approved, computerized electronic tissue compliance
device that quantifies the amount of tissue displacement per unit force
applied by a probe as it is pressed perpendicularly onto the skin
overlying a muscle. The Myotonometer is reliable (11, 12) and valid for
use with individuals with neurological involvement (3, 13).
The location for the Myotonometer probe placement was marked over
the biceps brachii muscle approximately 2 cm distal to the biceps brachii
EMG electrode. Measurements were taken at 8 force increments (0.25,
0.50, 0.75, 1.0, 1.25, 1.50, 1.75 and 2.00 kg). Computational software
created force-displacement curves and calculated area under the curve
(AUC) of these curves based on the data obtained. These data provide a
measure of muscle tone (stiffness) (13). For the present experiments,
myotonometric measurements of biceps brachii muscle stiffness were
acquired at rest, during MVC, during voluntary reaching and during
passive movement of the subject’s arm.
Data acquisition procedures
Following DTR, MAS and Fugl-Meyer data acquisition, subjects were
positioned in the upper extremity armature. Chair height was adjusted
so that the subject’s test shoulder was held in 908 of shoulder abduction.
The forearm was placed in a pronated position within the armature and
secured at the midpoint of the forearm and the upper arm by Velcro
straps. The subject’s trunk was stabilized with adjustable straps, one
around the waist and one around the chest.
The subjects’ uninvolved upper extremity was tested first, followed by
the involved arm. Resting Myotonometer readings were taken once the
subject was positioned in the upper extremity testing apparatus. The
subject’s arm was placed in a maximally lengthened position of shoulder
horizontal abduction and elbow extension (Fig. 1). Two sets of
Myotonometer measurements of biceps brachii muscle stiffness were
recorded from this position.
Resting stiffness trials were followed by MVCs of the biceps and
triceps brachii muscles with the elbow joint positioned at 758 of elbow
flexion and a self-selected position of shoulder horizontal adduction.
Subjects were instructed to build slowly into a maximal effort over a
5-second period. Five seconds of maximal effort sEMG data were
recorded for future root mean square (RMS) analysis. Maximal effort
was determined post hoc by finding the peak RMS activity (Biopac
signal analysis software) during the 5-second trial and computing the
RMS of 9/1 second on either side of this peak. Myotonometric
measurements of the biceps brachii muscle were taken during the
maximal effort of the contraction.
Following MVC data collection, subjects were placed in the starting
position for reaching trials. This consisted of 908 of elbow flexion and
908 of shoulder horizontal adduction (Fig. 1). The target was placed at
the maximum distance the subject could actively reach using elbow
extension and shoulder horizontal abduction.
With each subject’s arm aligned in the start position, the subject was
instructed to look at the target and reach towards it at a self-selected
speed as if they were ‘‘reaching for a glass of water.’’ This movement
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required the subject to extend the elbow and horizontally abduct the
shoulder. This type of movement is often referred to as a movement ‘‘out
of synergy.’’ sEMG recordings were obtained prior to and during
reaching. Myotonometric measurements of the biceps brachii muscle
coincided with target acquisition. Five reaching trials were performed.
Following the voluntary reaching task, sEMG and myotonometric
data were obtained during a passive reaching movement. For the passive
reaching movement, subjects remained relaxed while the armature was
moved manually with the same velocity and time to target as recorded
during voluntary reach. A computerized clock was used for this
determination and practice trials were used to ensure consistency prior
to data collection trials. Five trials of passive movement were obtained.
In order to be considered a valid trial for data analysis, each passive trial
was within 9/10% of time to target as during voluntary reaching trials.
Data analysis procedures
Biceps brachii muscle stiffness measurements. Myotonometric measure-
ments were obtained from the involved and uninvolved biceps brachii
muscles. The percentage difference in stiffness between the 2 extremities
was computed for each subject and grouped data used for subsequent
correlational statistical analysis as presented in Table II. Differences in
biceps brachii stiffness were calculated during voluntary movements
(Table II: column 2, row 2) and during passive movements of each
extremity (Table II: column 1, row 1).
Biceps and triceps brachii paresis. The presence and amount of biceps
and triceps brachii muscle paresis were determined by comparing the
RMS of each muscle during MVC trials. The percent difference between
the involved and uninvolved extremities was calculated (e.g. biceps RMS
during MVC of involved extremity was compared to biceps RMS of
uninvolved extremity. Grouped means were used for correlational
analyzes (Table II: columns/rows 6 and 7).
Muscle co-contraction. Muscle co-contraction, between the biceps and
triceps brachii muscles, were obtained during the following conditions:
(i ) biceps brachii MVC trials, (ii ) triceps brachii MVC trials, and (iii )
during voluntary reaching task trials.
As previously described for MVC trials, 2-seconds of sEMG data
representing the subject’s maximal elbow flexion or extension efforts
were used for analysis. The triceps and biceps RMS was computed. For
elbow extension trials, the triceps RMS value set as 100% and any biceps
brachii activation that occurred during this time was computed as a
percentage of this value. If the biceps brachii was not active during
triceps contraction it received a value of zero. If the biceps brachii
amplitude was one-half that of the triceps it received a value of 50%, and
so on. Grouped means were used for further correlational analyzes.
These data are represented in Table II (% co-contraction involved triceps
MVC). Similar procedures were followed for elbow flexion trials, but
with RMS values for the biceps brachii set as 100%.T
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Fig. 1. Start (top ) and end (bottom ) positions (target acquisition) for
voluntary and passive movement reaching tasks. The small vertical
rectangle represents the target position during testing.
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Table II. Impairment and motor performance correlation matrix table. Within each cell, the top number is the r-value, the bottom number is the p-value. Bold numbers indicate significance. Muscle
stiffness comparisons are represented within the first 2 columns and rows
% Difference
between
uninvolved
and involved
passive
% Difference
between
uninvolved
and involved
active
Elbow flexor
MAS
Biceps
brachii
DTR Fugl-Meyer
Biceps
paresis
Triceps
paresis
%
Co-contraction
mV of
involved
%
Co-contraction
mV of
uninvolved
%
Co-contraction
involved
during
triceps MVC
%
Co-contraction
involved
during biceps
MVC
% Difference
between
uninvolved &
involved passive
Correlation
sig.
(2-tailed)
% Difference
between
uninvolved &
involved active
Correlation 0.797
sig.
(2-tailed)
0.002
Elbow flexor MAS Correlation /0.091 /0.150
sig.
(2-tailed)
0.778 0.642
Biceps
brachii DTR
Correlation /0.453 /0.366 /0.161
sig.
(2-tailed)
0.139 0.241 0.600
Fugl-Meyer Correlation 0.485 0.428 /0.155 /0.081
sig.
(2-tailed)
0.110 0.165 0.612 0.792
Biceps
paresis
Correlation /0.239 /0.422 0.114 0.149 /0.667
sig.
(2-tailed)
0.455 0.171 0.712 0.626 0.013
Triceps
paresis
Correlation /0.160 /0.269 0.119 0.153 /0.752 0.789
sig.
(2-tailed)
0.619 0.398 0.699 0.619 0.003 0.001
% Co-contraction
mV of involved
Correlation /0.164 /0.394 0.292 /0.181 /0.762 0.683 0.756
sig.
(2-tailed)
0.652 0.259 0.384 0.594 0.006 0.021 0.007
% Co-contraction
mV of uninvolved
Correlation /0.124 0.053 0.208 /0.331 /0.309 /0.015 0.158 0.563
sig.
(2-tailed)
0.702 0.871 0.495 0.270 0.305 0.961 0.606 0.071
% Co-contraction
involved triceps
MVC
Correlation /0.207 /0.474 /0.156 0.137 /0.500 0.475 0.645 0.551 /0.223
sig.
(2-tailed)
0.542 0.141 0.647 0.688 0.118 0.140 0.032 0.099 0.510
% Co-contraction
involved biceps
Correlation
sig.
0.359
0.309
0.353
0.317
/0.091
0.803
/0.586
0.075
/0.351
0.320
0.535
0.111
0.508
0.134
0.312
0.380
/0.166
0.646
0.473
0.167
MVC (2-tailed)
% Difference between uninvolved and involved passive/Myotonometric muscle stiffness measurements of the differences between extremities during passive movements; % Difference between
uninvolved and involved active/Myotonometric muscle stiffness measurements indicating differences between extremities during voluntary movements: Triceps/biceps muscle co-contraction
values are represented during voluntary reaching tasks (% co-contraction mV) and also during biceps and triceps MVC trials (% co-contraction . . . MVC). MVC/maximum voluntary contraction;
DTR/deep tendon reflexes; MAS/modified Ashworth scale; mV/millivolts.
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Co-contraction was also determined during voluntary reaching tasks.
The onset and duration of triceps brachii EMG activity was deter-
mined (visual displacement from baseline; Biopac Software Systems).
Root mean square values were calculated for the duration of the triceps
EMG activity. This same time period was used to analyze any
concomitant biceps brachii EMG activity. Biceps brachii EMG
amplitudes were determined using the same RMS analyses and
compared to triceps brachii RMS values. A percentage of biceps
brachii co-contraction was derived using the triceps brachii RMS value
as 100%.
Statistical analysis
Dependent variables consisted of Fugl-Meyer assessment, the modified
Ashworth scale, DTRs, biceps/triceps RMS during MVC (paresis),
myotonometric measurements of biceps brachii muscle stiffness at rest
and during voluntary and passive reaching tasks and biceps and triceps
brachii percent co-contraction (RMS) during voluntary and passive
reaching. A correlation matrix was generated to assess the degree of
correlation among the variables. Pearson’s product-moment coefficient
of correlation was used for parametric data (myotonometric, sEMG and
Fugl-Meyer data). A Spearman’s rank correlation coefficient was used
for non-parametric data (MAS and DTRs). Not all of the ranges of the
MAS or DTR data were represented in our subject population.
Correlational analysis is not possible with empty bins. Modified Ash-
worth and DTR data, therefore, were condensed into the following
groupings: the MAS scores (range 1.03.0) were assigned to 1 of 4
groups: score of 1/group 1; score of 1//group 2; score of 2/group 3;
score of 3/group 4. The DTR data (range 24) were assigned to 1 of 3
groups: scores 23/group 1; scores of 3.5/group 2; scores of 4/group
3. The following scale was used for interpretation of correlation:
1.000.90/very high; 0.890.70/high; 0.690.50/moderate; 0.49
0.26/low; and less than 0.25/poor (14). Paired t -test comparisons
were used to analyze within subject, between limb differences for
myotonometric and sEMG data. Statistical significance was set at
p 5/0.05.
RESULTS
Fugl-Meyer Upper Extremity Motor Function Test correlations
Of the 14 parameters examined for correlation to the Fugl-
Meyer Upper Extremity Motor Function Test, only 3 had
significant associations. These were biceps paresis (r/0.667;
p/0.013), triceps paresis (r/0.752; p/0.003) and co-
contraction (the amplitude of biceps brachii activation during
the voluntary reaching task) (r/0.762; p/0.006).
Biceps and triceps brachii paresis correlations
Triceps and biceps brachii paresis of the involved upper
extremity were highly correlated (r/0.789; p/0.001). Triceps
paresis was also significantly correlated to excessive biceps
brachii co-contraction (increased biceps brachii amplitudes)
that occurred during voluntary reaching at self-selected speeds
(r/0.756; p/0.007) and the excess biceps brachii co-contrac-
tion that also occurred during triceps brachii MVC trials (r/
0.645; p/0.032). Biceps brachii paresis was significantly
correlated to its level of activation (co-contraction) during the
voluntary reaching task (r/0.683; p/0.021).
Co-contraction correlations
As reported previously, biceps brachii EMG amplitudes (a
measure of co-contraction) during the voluntary reaching
task, correlated with biceps (r/0.683; p/0.021) and triceps
(r/0.756; p/0.007) brachii paresis and Fugl-Meyer testing
(r/0.762; p/0.006). The amount of biceps brachii co-
contraction that occurred during voluntary reaching also had
a moderate but non-significant correlation to the co-contraction
that occurred during triceps brachii MVC testing (r/0.551; p/
0.099).
The only significant correlation, with regard to co-contrac-
tion, that occurred during MVC testing of either the biceps or
triceps brachii was the relationship between biceps co-contrac-
tion during triceps brachii MVC testing and paresis of the
triceps brachii (r/0.645; p/0.032).
Comparisons between involved and uninvolved biceps brachii
EMG amplitudes during triceps brachii MVC trials, using
paired t -tests, showed significantly higher amplitudes of the
involved biceps brachii muscle. The mean difference was 14.17%
(SD 17.43), p/0.030 indicating more co-contraction of the
involved biceps brachii muscle.
Myotonometric muscle stiffness correlations
The relationship between muscle stiffness measurements ob-
tained during voluntary reaching and those obtained during
passive movements were highly correlated for both tested
extremities (uninvolved biceps brachii, (r/0.882 p/0.050):
involved biceps brachii, (r/0.853 p/0.068)). Biceps brachii
stiffness of the involved upper extremity during voluntary
reaching (AUC/19.20) and uninvolved stiffness measurements
(AUC/18.21) were not significantly different (p/0.712).
Similar findings were acquired during passive movement testing
(p/0.562). Differences between involved and uninvolved biceps
brachii stiffness obtained passively and differences obtained
during voluntary reaching were correlated (r/0.797; p/0.002).
These data indicate that absolute biceps brachii stiffness
measurements obtained during voluntary elbow extension at a
self-selected speed and passive elbow extension are not sig-
nificantly different and are highly correlated. Biceps brachii
sEMG (RMS during duration of activation) of the involved
upper extremity and that of the uninvolved upper extremity
were not significantly different (3.37 (SD 2.7) mV; 2.66 (SD
2.96) mV, respectively; p/0.319). The stiffness measurements
obtained during voluntary or passive movements did not
correlate significantly to the MAS, DTRs or Fugl-Meyer testing
(Table II).
DISCUSSION
Paresis of the biceps and triceps brachii and co-contraction of
the biceps brachii during voluntary reaching were the impair-
ments most significantly correlated to motor performance, as
measured by Fugl-Meyer Upper Extremity motor testing.
Paresis following stroke has been a general finding (1, 5, 15).
Biceps and triceps brachii paresis both correlated to increased
levels of biceps brachii co-contraction during voluntary reach-
ing (see Table II).
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Excessive co-contraction of a lengthening muscle post-stroke
does not appear to be as general of a finding as paresis. Studies
that examined co-contraction during MVCs of individuals post-
stroke, reported excess co-contraction of antagonist muscles (5,
7). This was not the case in studies that used either self-selected
speed or force of movements (6, 16). Increased force or speed
requirements appear to increase the amount of co-contraction.
The present study used self-selected speed of movement and no
increase in biceps brachii co-contraction or stiffness was noted.
In summary, the present study, and others, indicate that
lengthening muscle co-contraction increases in response to the
force generation required of the shortening muscles (5, 7, 17),
direction (6, 16, 18), speed of movement (15), and whether the
shortening muscle is a flexor or extensor (1, 15).
In the present study, there was a strong correlation between
biceps brachii co-contraction and Fugl-Meyer Upper Extremity
motor testing (r//0.76; p/0.006). However, when data from
all subjects were considered (n/13), excess co-contraction did
not appear to increase during voluntary movements. One
interpretation of these findings would be that individuals
post-stroke, in the absence of force requirements, move at
speeds that do not elicit co-contraction. However, those with
severe upper extremity limitations (lowest Fugl-Meyer scores)
co-contract regardless of agonist force and speed requirements.
The second aim of the study was to assess the relationship of
neurological testing procedures to muscle characteristic data
and motor performance. The MAS did not correlate with deep
tendon reflexes, muscle stiffness or upper extremity motor
performance (Table II). Others have reported a lack of a
relationship between the MAS and stretch reflexes or muscle
stiffness (4, 19, 20). It would appear that the MAS is an
inappropriate test to assess muscle tone or the lack of
physiological correlations are secondary to statistical limitations
of the measurement. For example, poor MAS reliability (21)
increase variance, and clustering of scores, secondary to poor
MAS discriminative ability (22), will both negatively affect
correlation. Despite these limitations, the MAS has moderate
correlations with self-rated spasticity scores (23).
The third aim of the study was to assess the correlation
between passive measurements of biceps brachii muscle
stiffness and those obtained during voluntary reaching.
Clinically, myotonometric measurements of muscle stiffness
are typically obtained from a muscle at rest (3, 12, 13). It was
of interest to determine if these passive measurements were
indicative of stiffness changes of a lengthening muscle that
might occur during functional tasks such as voluntary reach-
ing. Results indicated strong correlations among the measure-
ments. Measurements obtained from a resting muscle,
therefore, provide a clinical prediction of the amount of
lengthening muscle stiffness that can be anticipated during
voluntary reaching tasks. Myotonometric data, however, did
not indicate significantly increased biceps brachii stiffness of
the involved upper extremity during reaching tasks. Previous
work, using high velocity or large amplitude torque motor
induced stretches, reported increased stiffness of the lengthen-
ing muscle of subjects with chronic hemiparesis (3, 24).
Furthermore, spastic muscle biopsies have shown the muscles
to be atrophic, shorter and stiffer than normal muscle (25).
The current study assessed stiffness of the lengthening muscle
during voluntary movement at a self-selected speed and only
through a range that the subject could obtain using volitional
effort. It is possible that agonist muscle paresis limited the
available range before opposing muscle stiffness increases
became measurable or that self-selected speeds were of a
velocity that did not elicit reflex-induced increases in length-
ening muscle stiffness.
Spastic muscles typically demonstrate a velocity-dependent
resistance to stretch (26). During self-selected movement speeds,
however, stretch reflexes of a lengthening muscle do not appear
to impede movement in any way (1, 27, 28). It would appear
that although increased passive muscle stiffness and decreased
reflex thresholds are indeed present in individuals with chronic
hemiparesis post stroke, these impairments do not appear to be
the primary limitations during voluntary, unperturbed move-
ment to a predicted target.
Present findings clearly indicate that paresis and co-contrac-
tion of a lengthening muscle contribute to upper extremity
dysfunction post-stroke. Additionally, triceps brachii paresis
and biceps brachii co-contraction are strongly correlated. These
findings pose considerable challenges for clinicians because
interventions that decrease excess tone and co-contraction, such
as various pharmacological and injection protocols, tend to
cause muscle paresis. Myotonometric measurements might be
useful in monitoring these treatment effects since the device
quantifies muscle stiffness (tone) and measurements taken
during isometric muscle contraction quantify muscle strength
(29, 30). The study adds to a body of literature (20, 23, 31) that
does not support the continued use of the MAS as a clinical or
research tool because of validity/reliability issues and because it
does not correlate to stretch reflexes, muscle stiffness, or upper
extremity motor performance. The present study emphasized
correlations among impairments and motor performance.
Intervention studies will greatly assist in determining the
causality of the relationships among impairment, motor per-
formance and function.
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